7 Recruiting Metastatic Prostate Cancer Phase 1 / Phase 2 Clinical Trials
Active phase 1 / phase 2 studies for metastatic prostate cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Metastatic Prostate Cancer studiesPhase 1 / Phase 2 Studies for Metastatic Prostate Cancer
🔵 Active, Not Recruiting Phase1 / Phase2
Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer
📍 Research Site — Detroit, Michigan
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Study of AZD0754 in Participants With Metastatic Prostate Cancer
📍 Research Site — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
📍 Research Site — Fayetteville, Arkansas
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
📍 Research Site — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer
📍 Research Site — Orlando, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
📍 Rocky Mountain Cancer Center — Colorado Springs, Colorado
View Study & Checklist ➔